IL10 and metabolic dysfunction-associated steatotic liver disease: For example, in NAFLD-HCC, the gut microbiota induced high levels of SCFAs such as butyrate, which was correlated with increased IL-10+ Tregs but decreased CD8+ cells [28], seemingly not consistent with its anti-HCC effect.